XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash $ 1,519,182 $ 619,249
Restricted cash 0 3,000,000
Accounts receivable 73,671 53,202
Deferred contract fulfillment costs 17,955 14,147
Prepayments and other current assets 552,876 174,369
Total current assets 2,163,684 3,860,967
Note receivable 1,000,000 0
Fixed assets, net 3,789,288 2,687,727
Intangible assets 32,283 20,000
Total Assets 6,985,255 6,568,694
Current liabilities:    
Accounts payable 472,327 162,308
Accrued expenses 768,483 222,699
Deferred revenue 37,149 31,437
Total current liabilities 1,277,959 416,444
Investor demand payable 0 3,000,000
Total liabilities 1,277,959 3,416,444
Commitments and contingencies (Note 12)
Redeemable convertible preferred stock, $0.01 par value, 1,000,000 shares authorized; 168 shares issued and outstanding ($168,496 aggregate liquidation value) 168,496 168,496
Stockholders’ equity:    
Common stock, $0.01 par value, 100,000,000 shares authorized; 30,216,009 and 28,516,009 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 302,159 285,159
Additional paid-in capital 17,280,641 11,170,666
Accumulated deficit (12,044,000) (8,472,071)
Total stockholders’ equity 5,538,800 2,983,754
Total liabilities and stockholders’ equity $ 6,985,255 $ 6,568,694